Evidence map›Paper›PMID 20190757›Full record

ArticleNature immunology2010

'Unlicensed' natural killer cells dominate the response to cytomegalovirus infection.

Mark T Orr, William J Murphy, Lewis L Lanier

Open access · greenAbstract read
In one paragraph

Article in Nature immunology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 148 papers.

0numbers the graph read from it
0cells of the map it votes in
148citing papers in PubMed
11.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

148 citing papers in PubMed, 271 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Immunology of Cytokine Storm Syndromes: Natural Killer Cells.Advances in experimental medicine and biology · 2024
    Review
  6. Article
  7. An inference model gives insights into innate immune adaptation and repertoire diversity.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  8. Human natural killer cells: Form, function, and development.The Journal of allergy and clinical immunology · 2023
    Review
  9. Review
  10. Persistence of KIRFrontiers in immunology · 2023
    Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Licensing Natural Killers for Antiviral Immunity.Pathogens (Basel, Switzerland) · 2021
    Review
  17. Review
  18. Review
  19. Article
  20. Review

88 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Mark T OrrDepartment of Microbiology and Immunology and the Cancer Research Institute, University of California, San Francisco, California, USA.
William J Murphy
Lewis L Lanier
Cancer Research Institute · USUniversity of California, Davis · US

Funding

NK MemoryR01AI068129 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LANIER, LEWIS LEE · 2006 to 2020
$6.0M
NK and T Cell Costimulation by NKG2D/DAP10R37AI066897 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LANIER, LEWIS LEE · 2006 to 2015
$3.8M
NIAID NIH HHS AI066897NIAID NIH HHS R01 AI068129NIAID NIH HHS R37 AI066897
6 · The paper itself

Abstract

Natural killer (NK) cells expressing inhibitory receptors that bind to self major histocompatibility complex (MHC) class I are 'licensed', or rendered functionally more responsive to stimulation, whereas 'unlicensed' NK cells lacking receptors for self MHC class I are hyporesponsive. Here we show that contrary to the licensing hypothesis, unlicensed NK cells were the main mediators of NK cell-mediated control of mouse cytomegalovirus infection in vivo. Depletion of unlicensed NK cells impaired control of viral titers, but depletion of licensed NK cells did not. The transfer of unlicensed NK cells was more protective than was the transfer of licensed NK cells. Signaling by the tyrosine phosphatase SHP-1 limited the proliferation of licensed NK cells but not that of unlicensed NK cells during infection. Thus, unlicensed NK cells are critical for protection against viral infection.

Indexed as

AnimalsCytomegalovirus InfectionsCytotoxicity, ImmunologicHistocompatibility Antigens Class IKiller Cells, NaturalLymphocyte ActivationMiceMice, Inbred C57BLNK Cell Lectin-Like Receptor Subfamily AProtein Tyrosine Phosphatase, Non-Receptor Type 6Histocompatibility Antigens Class INK Cell Lectin-Like Receptor Subfamily AProtein Tyrosine Phosphatase, Non-Receptor Type 6Ptpn6 protein, mouse

Identifiers

PMID20190757
PMCPMC2842453
OpenAlexW2165232639

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.